| REVIEW ARTICLE |
|
| Year : 2017 | Volume
: 6
| Issue : 2 | Page : 74-77 |
|
|
Bone morphogenetic proteins in periodontal tissue regeneration
Suryakanth Malgikar1, Uttam Akula2
1 Department of Periodontology, Kamineni Institute of Dental Sciences, Nalgonda, Telangana, India
2 Department of Periodontology, MNR Dental College, Sangareddy, Telangana, India
Correspondence Address:
Dr. Suryakanth Malgikar
Department of Periodontology, Kamineni Institute of Dental Sciences, Narketpally, Nalgonda - 508 254, Telangana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jdas.jdas_50_16
|
|
|
Progress in understanding the role of bone morphogenetic proteins (BMPs) in craniofacial and tooth development, the demonstration of stem cells in dental pulp, and accumulating knowledge on biomaterial scaffolds have set the stage for tissue engineering and regenerative therapy of the craniofacial complex. Furthermore, the recent approval by the US Food and Drug Administration (FDA; Rockville, MD, USA) of recombinant human BMPs for accelerating bone fusion in slow-healing fractures indicates that this protein family may prove useful in designing regenerative treatments in dental applications. In the near term, these advances are likely to be applied to endodontics and periodontal surgery; ultimately, they may facilitate approaches to regenerating whole teeth for use in tooth replacement. Early on, scientists focused on creating a suitable environment that favored the innate potential for regeneration. However, complex clinical protocols and extended treatments, in addition to inconsistent results, often brought treatment protocols out of favor. Predictable outcomes and minimally invasive protocols have become fundamental to clinicians and patients. Thus, novel regenerative concepts with improved or superior outcomes, predictability, and minimally invasive protocols are being developed and considered.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
